Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Thrombopoietin receptor agonist and rituximab combination therapy in patients with refractory primary immune thrombocytopenia.
Blood Coagul Fibrinolysis. 2024 Apr 1;35(3):108-114. doi: 10.1097/MBC.0000000000001283. Epub 2024 Feb 14.
Blood Coagul Fibrinolysis. 2024.
PMID: 38358901
An elevated systemic inflammation index is related to an inferior response to pomalidomide and dexamethasone treatment in patients with relapsed and refractory multiple myeloma.
Mikulski D, Robak P, Mirocha G, Ryżewska W, Stańczak K, Okoński K, Kościelny K, Robak T.
Mikulski D, et al. Among authors: ryzewska w.
Contemp Oncol (Pozn). 2023;27(3):139-146. doi: 10.5114/wo.2023.133506. Epub 2023 Dec 6.
Contemp Oncol (Pozn). 2023.
PMID: 38239862
Free PMC article.
Item in Clipboard
Risk Factors of Infection in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone (Rd) Regimen: Real-Life Results of a Large Single-Center Study.
Mikulski D, Robak P, Ryżewska W, Stańczak K, Kościelny K, Góra-Tybor J, Robak T.
Mikulski D, et al. Among authors: ryzewska w.
J Clin Med. 2022 Oct 7;11(19):5908. doi: 10.3390/jcm11195908.
J Clin Med. 2022.
PMID: 36233774
Free PMC article.
Item in Clipboard
Cite
Cite